Guideline updateMore research needed

Expert Guidelines for Managing Rett Syndrome Throughout Your Child's Life

A large group of medical experts created the first consensus-based care guidelines for Rett syndrome, covering the full lifespan from childhood through adulthood.

Educational summary - not medical advice. Always consult your child's care team.
Rett SyndromeDiagnosis·

Research Profile

Source:BMJ Paediatrics Open

Published: September 13, 2020

Added to SpecialCircle: July 24, 2026

Evidence Level

Guideline update

Research Status

More research needed

Key takeaways

  • •Rett syndrome affects approximately 1 in 10,000 girls under age 12, making it one of the most common genetic causes of intellectual disability in girls.
  • •RTT is caused by mutations in the MECP2 gene and is almost always a spontaneous (de novo) mutation — meaning it is not inherited and is very unlikely to recur in siblings.
  • •With good medical care, 70% of people with Rett syndrome live to at least 50 years of age, so planning for adult care is essential.
  • •Rett syndrome affects many body systems — not just the brain — requiring coordination between primary care doctors and multiple specialists.
  • •A checklist and detailed care guidance were developed by experts to help doctors and families navigate the complex, changing needs of individuals with RTT across their lifetime.

Source

BMJ Paediatrics Open · Peer-reviewed study

Read the original source

Plain-language summary

A team of leading Rett syndrome doctors and researchers worked together to create the first expert-agreed set of guidelines for caring for people with Rett syndrome at every stage of life. Because RTT is rare, many doctors have limited experience with it.

This guide — built from published research and expert opinion — gives healthcare providers and families a clear roadmap for managing the many medical challenges that come with RTT, from early childhood all the way into adulthood.

How it works

Science explained

Rett syndrome is caused by changes (mutations) in a gene called MECP2, found on the X chromosome. This gene makes a protein that acts like a master switch in the brain, helping to control how other genes are turned on or off during brain development. When the MECP2 gene doesn't work properly, the brain cannot develop and function normally, leading to the wide range of symptoms seen in RTT. Because females have two X chromosomes, the effects can vary depending on which X chromosome is more active in each cell — a process called X chromosome inactivation.

Why parents may care

If your daughter has been diagnosed with Rett syndrome, this study is directly relevant to her care. It means there is now an agreed-upon, expert-backed roadmap that her doctors can use to make sure nothing is missed — from managing breathing issues and scoliosis to nutrition, sleep, and seizures.

It also confirms that, with good care, your child can live well into adulthood, which makes long-term planning both important and worthwhile.

What this means for daily life

These guidelines remind families that Rett syndrome requires a team of specialists working together — not just one doctor. Parents can use this knowledge to advocate for comprehensive, coordinated care and regular check-ins across all body systems, not just neurological ones.

Planning ahead for the adult years is also encouraged, since most individuals with RTT live into their 50s.

What is still unknown

The guidelines acknowledge that the connection between specific MECP2 gene mutations and how severely a person is affected is not perfectly predictable — the same mutation can lead to different outcomes in different individuals. While animal studies have shown that symptoms can be reversed in mice, it is not yet known whether similar disease-modifying treatments will work in humans.

More research is also needed specifically on caring for adults with RTT, as most existing studies have focused on children.

Frequently asked questions about Rett Syndrome

Rett syndrome is caused by mutations in the MECP2 gene on the X chromosome. This gene is essential for normal brain development. These mutations are almost always spontaneous — meaning they are not passed down from parents — so the risk of it happening again in a family is very low.

Terminology glossary

MECP2 gene
A gene on the X chromosome that makes a protein essential for normal brain development; mutations in this gene cause Rett syndrome.
De novo mutation
A gene change that appears for the first time in a child and was not inherited from either parent — it happens spontaneously.
X chromosome inactivation
A natural process in females where one of their two X chromosomes is randomly 'switched off' in each cell, which is why symptoms of Rett syndrome can vary between individuals.
Delphi approach
A structured method where a group of experts share opinions, discuss differences, and come to an agreed-upon conclusion — used here to build the care guidelines.
Neurodevelopmental disorder
A condition that affects how the brain grows and develops, impacting skills like movement, communication, and learning.
Hand stereotypies
Repetitive, purposeless hand movements — like hand-wringing, clapping, or mouthing — that are a hallmark feature of Rett syndrome.

Questions to ask your doctor or therapist

  • ?Are you familiar with the 2020 consensus guidelines for Rett syndrome care, and are we following them for my child?
  • ?Which specialists should be part of my child's care team given that Rett syndrome affects so many body systems?
  • ?How does my child's specific MECP2 mutation affect what symptoms we should watch for most closely?
  • ?How should we start planning for my child's medical care as she transitions into adulthood?

⚕️ This research digest is for educational and community support purposes only. It is not medical advice, diagnosis, or treatment. Always speak with a qualified doctor, therapist, or medical professional before making decisions about care.

Related research

Understanding Real-World Use of Trofinetide for Rett Syndrome

This study looked at how people with Rett syndrome in the United States used trofinetide, an FDA-approved treatment, over time.

Understanding Who Receives Trofinetide for Rett Syndrome in the U.S.

A study found that only about one-quarter of eligible individuals with Rett Syndrome received the newly approved medication, Trofinetide, shortly after its approval in the United States.

Update on the NGN-401 Gene Therapy Study

Researchers have finished giving the study treatment to all 25 children in a major trial for a new gene therapy called NGN-401.

Study Investigates Immune System 'Gatekeepers' for Gene Therapy

A new clinical study is checking how many children have antibodies that might block gene therapy from working.

Talk to parents who truly understand

SpecialCircle is a free, private community. Ask questions, share what works, and never feel alone.

Find parents who understand Ask the community